封面
市場調查報告書
商品編碼
1390570

2023-2028 年按技術(合成定序、連接定序、焦磷酸定序、桑格定序等)、研究類型、實驗室類型、應用、最終用戶和地區分類的微生物組定序服務市場報告

Microbiome Sequencing Services Market Report by Technology (Sequencing by Synthesis, Sequencing by Ligation, Pyrosequencing, Sanger Sequencing, and Others), Research Type, Laboratory Type, Application, End User, and Region 2023-2028

出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年,全球微生物組定序服務市場規模達到18.463億美元。展望未來, IMARC Group預計到2028年市場規模將達到55.684億美元,2022-2028年複合年成長率(CAGR)為20.20%。大眾傳染病發病率的增加、對基於微生物組的治療(包括 FMT)的傾向不斷增加,以及微生物組測序在獸醫醫學中的日益採用是推動市場的一些主要因素。

微生物組定序服務涉及對居住在包括人體在內的各種環境中的微生物群落進行分析。它們是專門的程序,旨在識別和分析生活在特定生態系統(例如人類腸道、土壤或水)中的多種微生物。他們使用先進的脫氧核糖核酸 (DNA) 定序技術來解碼微生物的遺傳物質,使研究人員和醫療保健專業人員能夠了解這些微生物群落的組成、多樣性和功能。

大眾傳染病發病率的不斷上升,促進了對用於研究宿主與病原體關係的微生物組測序服務的需求,從而導致世界各地對其服務的需求不斷增加。此外,人們越來越傾向於基於微生物組的治療,包括糞便微生物群移植(FMT),這需要準確的微生物組分析以確保治療效果和安全性,這有利於市場的成長。除此之外,獸醫學中擴大採用微生物組定序來了解動物健康、疾病預防和改善畜牧生產,這對市場產生了積極影響。此外,製藥業的擴張正在推動利用微生物組資料來開發新藥,特別是針對胃腸道疾病的新藥,這有助於市場成長。此外,擴大採用依賴數據驅動決策的精準農業實踐,正在推動市場成長。

微生物組定序服務市場趨勢/促進因素:

個人化醫療和療法的增加

隨著個人化醫療的日益普及,對微生物組定序服務的需求不斷增加,以便為個別患者提供量身定做的治療和介入措施。對微生物組測序服務需求背後的驅動力之一是認知到一個人的每個微生物組都是獨特的,並且可以顯著影響他們對治療的反應。無論是最佳化益生菌方案、指導飲食建議,或是預測藥物療效,微生物組資料都是不可或缺的。患者和醫療保健提供者擴大尋求這些見解,以實現更好的治療結果、最大限度地減少不良反應並增強整體健康。因此,隨著個人化醫療成為現代醫療保健的核心原則,對微生物組定序服務的需求不斷成長。

消費者意識和健康的提高

消費者對微生物組在健康和保健中的作用的認知一直在穩步提高。人們對自己的健康變得更加積極主動,尋求最佳化微生物組以改善福祉的方法。這一趨勢是由直接面對消費者的微生物組測試套件的可用性推動的,該套件為個人提供了對其腸道微生物群的深入了解。隨著消費者更了解微生物組與各個健康面向之間的聯繫,他們開始轉向微生物組定序服務來進行深入分析和個人化建議。公眾興趣的激增正在推動對微生物組測序服務的需求,因為個人尋求做出明智的生活方式選擇和飲食調整以促進更健康的微生物組。

不斷成長的監管要求和品質保證

醫療保健、農業和食品安全領域的監管機構越來越認知到微生物組資料在確保安全和品質標準方面的重要性。例如,在食品工業中,微生物組定序用於透過識別潛在的病原體或腐敗生物來監測和改善食品安全。同樣,農業監管機構可能要求進行微生物組評估,以確保永續的農業實踐。遵守這些法規需要利用微生物組定序服務來維持高品質標準,從而導致企業和組織不斷要求努力滿足法規要求並確保其產品的安全性。

微生物組定序服務產業細分:

IMARC Group提供了對市場報告各細分市場主要趨勢的分析,以及 2023 年至 2028 年全球、區域和國家層面的預測。我們的報告根據技術、研究類型、實驗室類型、應用和最終用戶對市場進行了分類。

按技術分類:

邊合成邊定序 (SBS)

連接定序 (SBL)

焦磷酸定序

桑格定序

其他

邊合成邊定序 (SBS) 主導市場

該報告基於該技術對市場進行了詳細的細分和分析。這包括邊合成邊定序 (SBS)、邊連接邊定序 (SBL)、焦磷酸定序、桑格定序等。根據該報告,合成定序(SBS)代表了最大的部分。 SBS 是微生物組定序服務背後的基礎技術。它用於揭示給定樣品中微生物的基因組成。在 SBS 過程中,微生物群落的 DNA 鏈被分解成各自的成分,然後精確地重建。這個過程依賴將螢光標記的核苷酸摻入到不斷生長的 DNA 鏈中,這些鏈在添加時會發出不同的訊號。這些訊號被檢測並轉化為基因序列,使科學家能夠識別樣本中存在的微生物的類型和數量。 SBS 高度準確且高效,這使其成為微生物組分析的基石,應用範圍從人類健康研究到環境監測。

依研究類型細分:

外包研究

內部研究

外包研究佔市場最大佔有率

報告還根據研究類型對市場進行了詳細的細分和分析。這包括外包研究和內部研究。報告稱,外包研究佔了最大的市場佔有率。在微生物組定序服務領域,研究常採用外包方法。這需要與擁有微生物組分析先進能力的外部研究合作夥伴或專業服務提供者合作。這些外包研究工作是由微生物組研究的複雜性和技術要求所驅動的。透過利用該領域現有實體的專業知識和資源,研究人員可以獲得尖端的定序技術、生物資訊學工具和特定領域的知識。這種合作模式促進了更全面、更有洞察力的微生物組研究,無論是在人類健康、環境科學或農業背景下,最終有助於這一新興領域的知識進步。

按實驗室類型分類:

乾燥實驗室

濕實驗室

濕實驗室在市場上佔有最大佔有率

該報告根據實驗室類型提供了詳細的市場細分和分析。這包括乾實驗室和濕實驗室。報告稱,濕實驗室佔了最大的市場佔有率。濕實驗室是微生物組定序初始階段發生的物理空間。這些實驗室處理實際樣本、進行 DNA 萃取並準備定序。濕實驗室配備了最先進的分子生物學儀器和技術,以確保微生物群落遺傳物質的完整性和品質。濕實驗室的科學家使用專門的方案來分離 DNA、擴增特定的興趣區域並準備定序文庫。這些精心控制的程序對於確保準確可靠的微生物組定序資料至關重要。樣本製備完成後,處理後的樣本將送往定序設施或乾燥實驗室進行進一步分析。濕實驗室是微生物組研究的實踐實驗部門,從樣本到資料的旅程從這裡開始。

按應用分類:

鳥槍式定序

標靶基因定序

RNA定序

全基因組定序

其他

鳥槍式定序佔據最大市場佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括鳥槍定序、標靶基因定序、RNA 定序、全基因組定序等。報告稱,鳥槍測序佔據了最大的市場佔有率。它是微生物組測序服務的強大而全面的應用。在這種方法中,對微生物群落的整個遺傳物質或 DNA 進行定序,而不專門針對任何基因或區域。該方法提供了樣本中微生物多樣性的整體視圖,使研究人員能夠識別存在的所有微生物並深入了解它們的功能潛力。鳥槍法定序對於探索未知或複雜的微生物組特別有用,因為它不需要事先了解感興趣的特定基因。它廣泛應用於環境研究,例如土壤和水微生物學,並且對於了解人類腸道微生物組的複雜性及其對健康的影響具有重要意義。透過闡明微生物群落的完整基因組成,鳥槍法定序有助於更深入地了解微生物在各種生態系統中的作用及其潛在應用。

按最終用戶分類:

製藥和生物技術公司

研究和學術機構

其他

製藥和生物技術公司主導市場

該報告提供了基於最終用戶的詳細市場細分和分析。這包括製藥和生物技術公司、研究和學術機構等。報告稱,製藥和生技公司佔最大部分。這些公司代表微生物組定序服務的主要最終用戶。這些公司利用微生物組資料來推動藥物發現、開發和治療介入的創新。透過與專業服務提供者合作,他們可以獲得尖端的定序技術和微生物組分析的專業知識。此次合作使製藥和生物技術公司能夠探索人類微生物組與健康之間的複雜關係,目標是確定新的藥物標靶、生物標記和候選治療藥物。此外,微生物組定序有助於開發益生菌和基於微生物組的療法,為一系列醫療狀況提供潛在的解決方案。因此,製藥和生物技術公司在將微生物組研究轉化為切實的醫療保健進步、最終造福患者並推動生命科學領域發展方面發揮關鍵作用。

按地區分類:

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位,佔據最大的微生物組測序服務市場佔有率

市場研究報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,北美佔據最大的市場佔有率。

人們對早期診斷和疾病檢測優勢的認知不斷加深,這是推動北美地區微生物組定序服務需求的主要因素之一。此外,大腸直腸癌(CRC)發病率的飆升有利於該地區市場的成長。除此之外,不斷成長的老年人口(更容易患上嚴重的疾病)正在對該地區的市場產生積極影響。

由於開發新藥的投資增加、廣泛的研發(R&D)活動、先進技術的整合等,亞太地區預計將穩定成長。

競爭格局:

領先公司正在微生物組定序服務中採用高通量定序,以實現對大量微生物樣本的同步分析,從而促進大規模研究並提供有關微生物群落組成的高解析度資料。他們還使用宏基因組學,使研究人員能夠對樣本中整個微生物群落的 DNA 進行測序,而無需分離單一物種,並能夠全面了解微生物組。此外,關鍵參與者正在將人工智慧 (AI) 和機器學習 (ML) 整合到微生物組資料分析中,幫助識別模式、預測微生物相互作用並發現與健康或疾病相關的生物標記,從而增強複雜微生物組資料集的可解釋性。

市場研究報告對競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括:

BaseClear BV

臨床微生物組學 A/S

Diversigen 公司(OraSure 科技公司)

梅里埃營養科學公司

Metabiomics 公司 (BioSpherex LLC)

微生物群洞察公司

微生物組治療有限公司

分子研究有限合夥人

Molzym 有限公司

Resphera 生物科學有限責任公司

上海睿博科技(RBT)有限公司

Zymo 研究公司

(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)

最近的發展:

2022年,Diversigen Inc(OraSure Technologies Inc.)推出了針對腸道微生物組樣本的宏轉錄組定序和分析服務。

本報告回答的關鍵問題

  • 2022年全球微生物組定序服務市場規模有多大
  • 2023-2028年全球微生物組定序服務市場的預期成長率是多少
  • 推動全球微生物組定序服務市場的關鍵因素有哪些
  • COVID-19 對全球微生物組定序服務市場有何影響
  • 基於該技術的全球微生物組定序服務市場的詳細情形如何
  • 根據研究類型,全球微生物組定序服務市場的細分如何
  • 根據實驗室類型,全球微生物組定序服務市場的細分如何
  • 基於應用的全球微生物組定序服務市場區隔如何
  • 基於最終用戶的全球微生物組定序服務市場的細分是什麼
  • 10. 全球微生物組定序服務市場的關鍵區域有哪些?
  • 11. 全球微生物組定序服務市場的主要參與者/公司有哪些?

本報告回答的關鍵問題

  • 2022 年全球微生物組定序服務市場規模有多大?
  • 2023-2028年全球微生物組定序服務市場的預期成長率是多少?
  • 推動全球微生物組定序服務市場的關鍵因素是什麼?
  • COVID-19 對全球微生物組定序服務市場有何影響?
  • 基於該技術的全球微生物組定序服務市場的詳細情形如何?
  • 根據研究類型,全球微生物組定序服務市場的細分如何?
  • 根據實驗室類型,全球微生物組定序服務市場的細分如何?
  • 基於應用的全球微生物組定序服務市場的詳細情形如何?
  • 基於最終用戶的全球微生物組定序服務市場的詳細情形如何?
  • 全球微生物組定序服務市場的關鍵區域有哪些?
  • 全球微生物組定序服務市場的主要參與者/公司有哪些?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球微生物定序服務市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:依科技分類的市場

  • 邊合成邊定序 (SBS)
    • 市場走向
    • 市場預測
  • 連接定序 (SBL)
    • 市場走向
    • 市場預測
  • 焦磷酸定序
    • 市場走向
    • 市場預測
  • 桑格定序
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章:按研究類型分類的市場細分

  • 外包研究
    • 市場走向
    • 市場預測
  • 內部研究
    • 市場走向
    • 市場預測

第 8 章:按實驗室類型分類的市場細分

  • 乾燥實驗室
    • 市場走向
    • 市場預測
  • 濕實驗室
    • 市場走向
    • 市場預測

第 9 章:按應用分類的市場區隔

  • 鳥槍式定序
    • 市場走向
    • 市場預測
  • 標靶基因定序
    • 市場走向
    • 市場預測
  • RNA定序
    • 市場走向
    • 市場預測
  • 全基因組定序
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章:最終用戶的市場區隔

  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 研究和學術機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章:按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 12 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章:價值鏈分析

第 14 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章:價格分析

第16章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • BaseClear BV
    • Clinical-Microbiomics A/S
    • Diversigen Inc (OraSure Technologies Inc.)
    • Merieux NutriSciences
    • Metabiomics Corporation (BioSpherex LLC)
    • Microbiome Insights Inc.
    • Microbiome Therapeutics LLC
    • Molecular Research LP
    • Molzym GmbH & Co. KG
    • Resphera Biosciences LLC
    • Shanghai Realbio Technology (RBT) Co. Ltd.
    • Zymo Research Corporation
Product Code: SR112023A4357

Abstract

The global microbiome sequencing services market size reached US$ 1,846.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 5,568.4 Million by 2028, exhibiting a growth rate (CAGR) of 20.20% during 2022-2028. The increasing incidences of infectious diseases among the masses, rising inclination towards microbiome-based therapeutics, including FMT, and the growing adoption of microbiome sequencing in veterinary medicine are some of the major factors propelling the market.

Microbiome sequencing services involve the analysis of microbial communities that inhabit various environments, including the human body. They are specialized procedures designed to identify and analyze the diverse microorganisms living in a particular ecosystem, such as the human gut, soil, or water. They use advanced deoxyribonucleic acid (DNA) sequencing technologies to decode the genetic material of microorganisms, which allows researchers and healthcare professionals to understand the composition, diversity, and function of these microbial communities.

Increasing incidences of infectious diseases among the masses are catalyzing the demand for microbiome sequencing services for studying host-pathogen relationships, which lead to rising demand for its services around the world. Moreover, the rising inclination towards microbiome-based therapeutics, including fecal microbiota transplantation (FMT), that necessitates accurate microbiome profiling to ensure treatment efficacy and safety is favoring the growth of the market. Apart from this, the growing adoption of microbiome sequencing in veterinary medicine for understanding animal health, disease prevention, and improving livestock production is influencing the market positively. In addition, the expansion of the pharmaceutical industry is driving the use of microbiome data to develop novel drugs, particularly those targeting gastrointestinal diseases, which is contributing to the market growth. Furthermore, the increasing adoption of precision agriculture practices, which rely on data-driven decision-making, is bolstering the market growth.

Microbiome Sequencing Services Market Trends/Drivers:

Increase in personalized medicine and therapies

With the rising use of personalized medicine, there is a rise in the demand for microbiome sequencing services to offer tailoring treatments and interventions to individual patients. One of the driving forces behind the demand for microbiome sequencing services is the recognition that each microbiome of a person is unique and can significantly impact their response to treatments. Whether it is optimizing probiotic regimens, guiding dietary recommendations, or predicting drug efficacy, microbiome data is indispensable. Patients and healthcare providers increasingly seek these insights to achieve better treatment outcomes, minimize adverse effects, and enhance overall wellness. Consequently, the demand for microbiome sequencing services is rising as personalized medicine is becoming a central tenet of modern healthcare.

Rise in consumer awareness and wellness

Consumer awareness about the role of microbiomes in health and wellness has been steadily increasing. People are becoming more proactive about their health, seeking ways to optimize their microbiomes for improved well-being. This trend is driven by the availability of direct-to-consumer microbiome testing kits that provide individuals with insights into their gut microbiota. As consumers gain a better understanding of the connections between their microbiome and various health aspects, they are turning to microbiome sequencing services for in-depth analysis and personalized recommendations. This surge in interest from the public is propelling the demand for microbiome sequencing services, as individuals seek to make informed lifestyle choices and dietary adjustments to promote a healthier microbiome.

Growing regulatory requirements and quality assurance

Regulatory bodies in healthcare, agriculture, and food safety are increasingly recognizing the importance of microbiome data in ensuring safety and quality standards. For instance, in the food industry, microbiome sequencing is used to monitor and improve food safety by identifying potential pathogens or spoilage organisms. Similarly, regulatory agencies in agriculture may require microbiome assessments to ensure sustainable farming practices. Compliance with these regulations necessitates the utilization of microbiome sequencing services to maintain high-quality standards, leading to a consistent demand from businesses and organizations striving to meet regulatory requirements and ensure the safety of their products.

Microbiome Sequencing Services Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on technology, research type, laboratory type, application, and end user.

Breakup by Technology:

Sequencing by Synthesis (SBS)

Sequencing by Ligation (SBL)

Pyrosequencing

Sanger Sequencing

Others

Sequencing by synthesis (SBS) dominates the market

The report has provided a detailed breakup and analysis of the market based on the technology. This includes sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing, and others. According to the report, sequencing by synthesis (SBS) represented the largest segment. SBS is the fundamental technology behind microbiome sequencing services. It is employed to unravel the genetic makeup of microorganisms in a given sample. During SBS, DNA strands from the microbial community are broken down into their individual components and then precisely reconstructed. This process relies on the incorporation of fluorescently labeled nucleotides into the growing DNA strands, which emit distinct signals as they are added. These signals are detected and translated into the genetic sequence, which enables scientists to identify the types and quantities of microorganisms present in the sample. SBS is highly accurate and efficient, which makes it a cornerstone of microbiome analysis, with applications ranging from human health research to environmental monitoring.

Breakup by Research Type:

Outsourced Research

Internal Research

Outsourced research holds the largest share in the market

A detailed breakup and analysis of the market based on the research type has also been provided in the report. This includes outsourced research and internal research. According to the report, outsourced research accounted for the largest market share. In the realm of microbiome sequencing services, research frequently encompasses an outsourced approach. This entails collaborating with external research partners or specialized service providers who possess advanced capabilities in microbiome analysis. These outsourced research endeavors are driven by the complexity and technical demands of microbiome studies. By leveraging the expertise and resources of established entities in this field, researchers can access cutting-edge sequencing technologies, bioinformatics tools, and domain-specific knowledge. This collaborative model fosters more comprehensive and insightful microbiome investigations, whether in the context of human health, environmental science, or agriculture, ultimately contributing to the advancement of knowledge in this burgeoning field.

Breakup by Laboratory Type:

Dry Labs

Wet Labs

Wet labs hold the largest share in the market

The report has provided a detailed breakup and analysis of the market based on the laboratory type. This includes dry labs and wet labs. According to the report, wet labs accounted for the largest market share. Wet labs are the physical spaces wherein the initial stages of microbiome sequencing occur. These labs handle the actual samples, perform DNA extraction, and prepare them for sequencing. Wet labs are equipped with state-of-the-art molecular biology instruments and techniques to ensure the integrity and quality of the genetic material from microbial communities. Scientists in wet labs use specialized protocols to isolate DNA, amplify specific regions of interest, and prepare sequencing libraries. These meticulously controlled procedures are essential to ensure accurate and reliable microbiome sequencing data. Once the sample preparation is complete, the processed samples are sent to sequencing facilities or dry labs for further analysis. Wet labs are the hands-on, experimental arm of microbiome research, where the journey from sample to data begins.

Breakup by Application:

Shotgun Sequencing

Targeted Gene Sequencing

RNA Sequencing

Whole Genome Sequencing

Others

Shotgun sequencing holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing, and others. According to the report, shotgun sequencing accounted for the largest market share. It is a powerful and comprehensive application of microbiome sequencing services. In this approach, the entire genetic material, or DNA, of a microbial community is sequenced without specifically targeting any genes or regions. This method provides a holistic view of the microbial diversity within a sample, which allows researchers to identify all the microorganisms present and gain insights into their functional potential. Shotgun sequencing is particularly useful for exploring unknown or complex microbiomes, as it does not require prior knowledge of the specific genes of interest. It is widely applied in environmental studies, such as soil and water microbiology, and has significant relevance in understanding the human gut microbiome's complexity and its implications for health. By elucidating the complete genetic makeup of microbial communities, shotgun sequencing contributes to a deeper understanding of their roles in various ecosystems and their potential applications.

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Research and Academic Institutes

Others

Pharmaceutical and biotechnology companies dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical and biotechnology companies, research and academic institutes, and others. According to the report, pharmaceutical and biotechnology companies represented the largest segment. These companies represent key end users of microbiome sequencing services. These companies leverage microbiome data to drive innovation in drug discovery, development, and therapeutic interventions. By partnering with specialized service providers, they gain access to cutting-edge sequencing technologies and expertise in microbiome analysis. This collaboration enables pharmaceutical and biotechnology companies to explore the intricate relationship between the human microbiome and health with the goal of identifying novel drug targets, biomarkers, and therapeutic candidates. Additionally, microbiome sequencing aids in the development of probiotics and microbiome-based therapies, which offer potential solutions for a range of medical conditions. As such, pharmaceutical and biotechnology firms play a pivotal role in translating microbiome research into tangible healthcare advancements, ultimately benefiting patients and advancing the field of life sciences.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest microbiome sequencing services market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing knowledge about the advantages of early diagnosis and disease detection represents one of the primary factors driving the demand for microbiome sequencing services in the North American region. Moreover, the surging prevalence of colorectal cancer (CRC) is favoring the growth of the market in the region. Besides this, the growing geriatric population, that are more prone to develop severe medical conditions, is influencing the market positively in the region.

Asia Pacific is estimated to witness stable growth, owing to increasing investment in developing novel drugs, extensive research and development (R&D) activities, integration of advanced technologies, etc.

Competitive Landscape:

The leading companies are adopting the use of high throughput sequencing in microbiome sequencing services to enable the simultaneous analysis of numerous microbial samples, which facilitates large-scale studies and delivers high-resolution data on microbial community composition. They are also using metagenomics that allows researchers to sequence the DNA of an entire microbial community in a sample without isolating individual species and enables a holistic view of the microbiome. Moreover, key players are integrating artificial intelligence (AI) and machine learning (ML) into microbiome data analysis that help identify patterns, predict microbial interactions, and discover biomarkers associated with health or disease, which enhances the interpretability of complex microbiome datasets.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

BaseClear B.V.

Clinical-Microbiomics A/S

Diversigen Inc (OraSure Technologies Inc.)

Merieux NutriSciences

Metabiomics Corporation (BioSpherex LLC)

Microbiome Insights Inc.

Microbiome Therapeutics LLC

Molecular Research LP

Molzym GmbH & Co. KG

Resphera Biosciences LLC

Shanghai Realbio Technology (RBT) Co. Ltd.

Zymo Research Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In 2022, Diversigen Inc (OraSure Technologies Inc.) launched metatranscriptomic sequencing and analysis services for gut microbiome samples.

Key Questions Answered in This Report

  • 1. What was the size of the global microbiome sequencing services market in 2022?
  • 2. What is the expected growth rate of the global microbiome sequencing services market during 2023-2028?
  • 3. What are the key factors driving the global microbiome sequencing services market?
  • 4. What has been the impact of COVID-19 on the global microbiome sequencing services market?
  • 5. What is the breakup of the global microbiome sequencing services market based on the technology?
  • 6. What is the breakup of the global microbiome sequencing services market based on the research type?
  • 7. What is the breakup of the global microbiome sequencing services market based on the laboratory type?
  • 8. What is the breakup of the global microbiome sequencing services market based on the application?
  • 9. What is the breakup of the global microbiome sequencing services market based on the end user?
  • 10. What are the key regions in the global microbiome sequencing services market?
  • 11. Who are the key players/companies in the global microbiome sequencing services market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Microbiome Sequencing Services Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Sequencing by Synthesis (SBS)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sequencing by Ligation (SBL)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Pyrosequencing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Sanger Sequencing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Research Type

  • 7.1 Outsourced Research
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Internal Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Laboratory Type

  • 8.1 Dry Labs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Wet Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Shotgun Sequencing
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Targeted Gene Sequencing
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 RNA Sequencing
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Whole Genome Sequencing
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research and Academic Institutes
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 BaseClear B.V.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Clinical-Microbiomics A/S
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Diversigen Inc (OraSure Technologies Inc.)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Merieux NutriSciences
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Metabiomics Corporation (BioSpherex LLC)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Microbiome Insights Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Microbiome Therapeutics LLC
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Molecular Research LP
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Molzym GmbH & Co. KG
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Resphera Biosciences LLC
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Shanghai Realbio Technology (RBT) Co. Ltd.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zymo Research Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Microbiome Sequencing Services Market: Major Drivers and Challenges
  • Figure 2: Global: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Microbiome Sequencing Services Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Microbiome Sequencing Services Market: Breakup by Research Type (in %), 2022
  • Figure 6: Global: Microbiome Sequencing Services Market: Breakup by Laboratory Type (in %), 2022
  • Figure 7: Global: Microbiome Sequencing Services Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Microbiome Sequencing Services Market: Breakup by End User (in %), 2022
  • Figure 9: Global: Microbiome Sequencing Services Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Microbiome Sequencing Services (Sequencing by Synthesis -SBS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Microbiome Sequencing Services (Sequencing by Synthesis -SBS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Microbiome Sequencing Services (Sequencing by Ligation -SBL) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Microbiome Sequencing Services (Sequencing by Ligation -SBL) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Microbiome Sequencing Services (Pyrosequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Microbiome Sequencing Services (Pyrosequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Microbiome Sequencing Services (Sanger Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Microbiome Sequencing Services (Sanger Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Microbiome Sequencing Services (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Microbiome Sequencing Services (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Microbiome Sequencing Services (Outsourced Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Microbiome Sequencing Services (Outsourced Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Microbiome Sequencing Services (Internal Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Microbiome Sequencing Services (Internal Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Microbiome Sequencing Services (Dry Labs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Microbiome Sequencing Services (Dry Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Microbiome Sequencing Services (Wet Labs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Microbiome Sequencing Services (Wet Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Microbiome Sequencing Services (Shotgun Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Microbiome Sequencing Services (Shotgun Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Microbiome Sequencing Services (Targeted Gene Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Microbiome Sequencing Services (Targeted Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Microbiome Sequencing Services (RNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Microbiome Sequencing Services (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Microbiome Sequencing Services (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Microbiome Sequencing Services (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Microbiome Sequencing Services (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Microbiome Sequencing Services (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Microbiome Sequencing Services (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Microbiome Sequencing Services (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Microbiome Sequencing Services (Research and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Microbiome Sequencing Services (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Microbiome Sequencing Services (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Microbiome Sequencing Services (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: North America: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: North America: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: United States: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: United States: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Canada: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Canada: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Asia-Pacific: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Asia-Pacific: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: China: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: China: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Japan: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Japan: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: India: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: India: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: South Korea: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: South Korea: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Australia: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Australia: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Indonesia: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Indonesia: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Europe: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Europe: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Germany: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Germany: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: France: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: France: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: United Kingdom: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: United Kingdom: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Italy: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Italy: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Spain: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Spain: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Russia: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Russia: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Latin America: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Latin America: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Brazil: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Brazil: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Mexico: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Mexico: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Others: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Others: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Middle East and Africa: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Middle East and Africa: Microbiome Sequencing Services Market: Breakup by Country (in %), 2022
  • Figure 92: Middle East and Africa: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Global: Microbiome Sequencing Services Industry: SWOT Analysis
  • Figure 94: Global: Microbiome Sequencing Services Industry: Value Chain Analysis
  • Figure 95: Global: Microbiome Sequencing Services Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Microbiome Sequencing Services Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Microbiome Sequencing Services Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 3: Global: Microbiome Sequencing Services Market Forecast: Breakup by Research Type (in Million US$), 2023-2028
  • Table 4: Global: Microbiome Sequencing Services Market Forecast: Breakup by Laboratory Type (in Million US$), 2023-2028
  • Table 5: Global: Microbiome Sequencing Services Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Microbiome Sequencing Services Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Microbiome Sequencing Services Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Microbiome Sequencing Services Market: Competitive Structure
  • Table 9: Global: Microbiome Sequencing Services Market: Key Players